Prof Dr. KUMARASWAMY GANDLA | PHARMACEUTICAL ANALYSIS | Best Research Article Award

Prof Dr. KUMARASWAMY GANDLA | PHARMACEUTICAL ANALYSIS | Best Research Article Award

Chaitanya Deemed to be University, India

Author Profile

Orchid

🎓 Early Academic Pursuits

Prof. (Dr.) Kumaraswamy Gandla embarked on his academic journey with a deep passion for pharmaceutical sciences. His dedication and perseverance led him to achieve significant academic milestones. He completed his Bachelor of Pharmacy (B.Pharm) from Acharya Nagarjuna University, Guntur, Andhra Pradesh, in 2007. Furthering his education, he obtained a Master of Pharmacy (M.Pharm) in Pharmaceutical Analysis from The Tamil Nadu Dr. M.G.R. Medical University, Chennai, in 2009. However, his quest for knowledge did not stop there. In 2017, he earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Kakinada, a testament to his commitment to research and academic excellence.

Adding another dimension to his expertise, he pursued a Postgraduate Diploma in Animal Welfare (PGDAW) from IGNOU, Hyderabad, in 2021, showcasing his dedication to ethical practices in pharmaceutical research. His academic foundation laid the groundwork for an illustrious career that seamlessly blended teaching, research, and administrative excellence.

🎬 Professional Endeavors

With over 17 years of experience in teaching and research, Prof. Kumaraswamy has made significant contributions to the field of pharmaceutical education. Currently serving as the Professor & Head of the Department of Pharmacy at Chaitanya (Deemed to be University) in Hyderabad, he plays a crucial role in shaping the next generation of pharmacists and researchers.

His career journey has seen him take on several key roles across esteemed institutions. Prior to his current position, he served as an Associate Professor and Head of the Department at Care College of Pharmacy, Warangal (2015–2021), Teegala Ram Reddy College of Pharmacy, Hyderabad (2014–2015), and Chilkur Balaji College of Pharmacy, Hyderabad (2013–2014). Earlier, he contributed as an Assistant Professor at Trinity College of Pharmaceutical Sciences, Karimnagar, and Srikrupa Institute of Pharmaceutical Sciences, Siddipet. His diverse experiences across multiple institutions have allowed him to bring innovative teaching methodologies and research initiatives to his students.

Beyond academia, he gained valuable industry experience working as an Executive in Quality Control and Analytical Research & Development (AR&D) at AstraZeneca Pharma Ltd., Bangalore (2008–2009). This industrial exposure has enabled him to bridge the gap between academic research and pharmaceutical industry applications, ensuring that his students receive a holistic education.

📚 Contributions and Research Focus

Prof. Kumaraswamy’s research primarily revolves around pharmaceutical analysis, drug development, and quality control. His extensive research work has been instrumental in advancing analytical methodologies for pharmaceutical compounds, ensuring drug safety and efficacy. His studies have contributed to enhancing regulatory compliance, analytical method validation, and bioanalytical techniques, all of which are critical for the pharmaceutical industry.

As a researcher, he has mentored numerous students, guiding them in their postgraduate and doctoral research projects. His work extends beyond academia into regulatory and ethical aspects of pharmaceutical sciences. His role as a Nominee of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) reflects his commitment to ethical research practices involving laboratory animals.

🏆 Accolades and Recognition

Prof. Kumaraswamy’s exemplary contributions to pharmaceutical sciences have earned him several prestigious accolades and professional memberships. He has been honored with Fellowships from reputed scientific societies, including the Fellowship of the Society for Applied Spectroscopy and Analytical Science (FSASS) and the Society for Research and Academic Professionals (SRAP). Additionally, he holds a Fellowship from the Institute of Chemists (F.I.C.), recognizing his expertise and contributions to analytical chemistry.

His professional engagements extend to various scientific committees and advisory boards, where he actively contributes to shaping pharmaceutical education and research policies. His participation in academic conferences, seminars, and workshops as a keynote speaker and panelist further demonstrates his influence in the field.

💡 Impact and Influence

Through his years of dedicated service, Prof. Kumaraswamy has made a lasting impact on pharmaceutical education and research. His mentorship has inspired numerous students to pursue careers in academia, research, and the pharmaceutical industry. By integrating industry insights into his teaching, he has played a pivotal role in bridging the gap between theoretical knowledge and practical applications.

His contributions to research and development have also influenced pharmaceutical regulatory standards, ensuring that drug formulations meet the highest quality and safety benchmarks. His work in pharmaceutical analysis continues to aid in the development of innovative analytical techniques, benefiting both academic and industrial sectors.

🌟 Legacy and Future Contributions

Looking ahead, Prof. Kumaraswamy remains committed to advancing pharmaceutical sciences through groundbreaking research and academic leadership. He aims to further strengthen research collaborations, promote ethical pharmaceutical practices, and mentor the next generation of scholars and scientists.

His vision includes fostering interdisciplinary research, embracing technological advancements in pharmaceutical analysis, and contributing to global health initiatives. With his extensive experience and unwavering dedication, Prof. Kumaraswamy Gandla continues to be a beacon of inspiration in the world of pharmaceutical education and research.

📝Notable Publications

Exploring compound suitability and employing DFT calculations, molecular docking, and dynamics simulation to investigate potent compounds from podophyllum medicinal plants for breast cancer therapy

Author(s): Srinivasarao Mande, Lalitha Repudi, Sanchari Goswami, P. Kumar Nallasivan, Kumaraswamy Gandla

Journal: Bulletin of the National Research Centre

Year: 2024

A Validated RP-HPLC Method for Quantitative Estimation of Guaifenesin in Bulk and Pharmaceutical Dosage Forms

Author(s): Vemireddy S., Kumaraswamy G., Jyothsna B., Bindu M.

Journal: Research Journal of Pharmacy and Technology

Year: 2023

Applications of magnetic nanomaterials in the fabrication of lateral flow assays toward increasing performance of food safety analysis: Recent advances

Author(s): Raed H. Althomali, Herlina Uinarni, Kumaraswamy Gandla, Abdulilah Mohammad Mayet, Rosario Mireya Romero-Parra, Ibrahem Cahalib, Khulood H. Oudaha, Abbas F. Almulla, Yashwant Singh Bisht

Journal: Food Bioscience

Year: 2023

Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer

Author(s): Kumaraswamy Gandla, Fahadul Islam, Mehrukh Zehravi, Anandakumar Karunakaran, Indu Sharma, M. Akiful Haque, Sanjay Kumar, Kumar Pratyush, Sachin A. Dhawale, Firzan Nainu et al.

Journal: Heliyon

Year: 2023

QbD driven targeted pulmonary delivery of dexamethasone-loaded chitosan microspheres: Biodistribution and pharmacokinetic study

Author(s): B.R. Asha, Prakash Goudanavar, G.S.N. Koteswara Rao, Kumaraswamy Gandla, N. Raghavendra Naveen, Shahnaz Majeed, Ravindran Muthukumarasamy

Journal: Saudi Pharmaceutical Journal

Year: 2023

Prof Maxime Breban | Prix du meilleur article de rechercher | Best Research Article Award

Prof Maxime Breban | Prix du meilleur article de rechercher

Université de Versailles-Saint-Quentin, France

Author Profile

Scopus 

Early Academic Pursuits 🎓

Professor Breban embarked on his medical journey at Paris hospitals, earning his Doctor of Medicine (MD) degree between 1984 and 1990. His passion for immunology and rheumatology led him to pursue a Doctorate (PhD), which he completed in 1994 under the auspices of the French National Institute for Medical Research. During this period, he honed his expertise in immuno-rheumatology, laying a solid foundation for his future endeavors.igasconference.com

Professional Endeavors 🏥

Following his PhD, Professor Breban undertook a post-doctoral fellowship at the Harold Simmons Research Center, University of Texas, Dallas, USA, from 1990 to 1993, under the mentorship of Professor Joel D. Taurog. This international experience enriched his research perspective and expertise. Upon returning to France, he served as a clinical fellow and subsequently as Associate Professor of Immunology at Cochin Hospital, Paris, from 1993 to 2002. In 2002, he joined the Rheumatology Division of Ambroise Paré Hospital in Boulogne-Billancourt as a Professor of Rheumatology and ascended to the role of Head of the Department in 2011. Concurrently, he has been directing a research team focused on chronic inflammation in rheumatic disorders, which transitioned from the Cochin Institute to the Faculty of Simone Veil-Santé in 2013.igasconference.com

Contributions and Research Focus 🔬

Professor Breban’s research primarily centers on the immunogenetics of ankylosing spondylitis and related spondyloarthritis. He has been the principal investigator and coordinator for numerous clinical and basic research projects. Over the past two decades, he has contributed to over 100 original papers and 40 review articles in the field of SpA. His work has significantly advanced the understanding of the genetic and environmental factors contributing to SpA, including the role of the microbiome in disease pathogenesis.igasconference.com

Accolades and Recognition 🏆

Throughout his illustrious career, Professor Breban has received several prestigious awards, including the American College of Rheumatology Fellowship Award for Excellence in Scientific Research in 1992 and the Guillaumat-Piel Prize from the Foundation for Medical Research in 2018. These accolades underscore his substantial contributions to rheumatology research and his dedication to advancing medical science.igasconference.com

Impact and Influence 🌍

Professor Breban’s influence extends beyond his research contributions. He has played pivotal roles in various scientific committees and societies, including serving as President of the Scientific Committee of the French Rheumatology Society from 1998 to 2004 and as a member of the Scientific Board of the French National Research Agency from 2012 to 2013. His involvement in these organizations has shaped research agendas and fostered collaborations within the rheumatology community.

Legacy and Future Contributions 🚀

As a dedicated educator, Professor Breban has been imparting knowledge in rheumatology to medical students since 1993 and has been involved in various master’s programs and university diplomas related to immunology and rheumatology. His commitment to teaching ensures the cultivation of future generations of rheumatologists. Looking ahead, Professor Breban continues to lead research initiatives aimed at unraveling the complexities of chronic inflammatory diseases, with the goal of developing innovative therapeutic strategies and improving patient outcomes.

In summary, Professor Maxime Breban’s career is marked by a profound dedication to the study and treatment of rheumatic diseases. His extensive research, leadership roles, and commitment to education have left an indelible mark on the field of rheumatology, promising continued advancements in understanding and managing these complex conditions.

📝Notable Publications

Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis


Authors: M. Beaufrère, Marie; M. Jacoutot, Manon; M.A. Breban, Maxime A.; S. Glatigny, Simon
Journal: Journal of Autoimmunity
Year: 2025

 Microbiota in spondyloarthritis: Where are we?

Authors: M.A. Breban, Maxime A.; M. Beaufrère, Marie; M. Jacoutot, Manon; S. Glatigny, Simon
Journal: Not provided
Year: Not provided

What is a severe axial spondyloarthritis?

Authors: F. Costantino, Félicie; M.A. Breban, Maxime A.; M.A. D’Agostino, Maria Antonietta
Journal: Not provided
Year: Not provided

 TGFβ signaling pathway is altered by HLA-B27 expression, resulting in pathogenic consequences relevant for spondyloarthritis

Authors: M. Lauraine, Marc; M. de Taffin de Tilques, Maxence; D. Melamed-Kadosh, Dganit; L.M. Araujo, Luiza M.; M.A. Breban, Maxime A.
Journal: Arthritis Research and Therapy
Year: 2024

Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop

Authors: D. Wendling, Daniel; M.A. Breban, Maxime A.; F. Costantino, Félicie; F.M. Verhoeven, Frank M.; C. Prati, Clément
Journal: Not provided
Year: Not provided

Mrs. Thalita Vitória Silva da Cruz | Servant Leadership | Best Researcher Award

Mrs. Thalita Vitória Silva da Cruz | Servant Leadership | Best Researcher Award

Federal University of Pernambuco (UFPE), Brazil

Author Profile

Orchid

Early Academic Pursuits 📚🔬

Thalita Victory Silva da Cruz embarked on her academic journey at the Federal University of Pernambuco (UFPE), Brazil, where she obtained her undergraduate degree in Speech Therapy in 2017. Her passion for the field was evident early on, as she engaged in multiple academic and extracurricular activities. She served as a monitor in Fundamentals of Speech Therapy, Human Anatomy, and Voice, demonstrating her dedication to both learning and teaching.

During her undergraduate years, she actively participated in scientific research, securing a spot in the Institutional Scientific Initiation Scholarship Program (PIBIC/CNPq) from 2016 to 2017. This experience solidified her interest in investigating speech-language disorders and innovative therapeutic approaches. She was also a founding member of the Academic League of Anatomy Applied to Dentistry (LA3O) and played an active role in the Academic Directory of Speech Therapy at UFPE.

Her research inclination and commitment to community service led her to participate in multiple extension projects, including Neonatal Hearing Screening, Telephonoaudiology for Zika virus and microcephaly, and Vestibular Rehabilitation. These early endeavors laid a strong foundation for her specialization in speech-language pathology, particularly in dysphagia, orofacial motricity, and voice disorders.

Professional Endeavors 🏥🎤

After completing her undergraduate degree, Thalita pursued a Master’s in Human Communication Health (2018-2020) at UFPE, under the guidance of Zulina Souza de Lira. Her research during this period delved into Parkinson’s disease, virtual reality, and acoustic stimulation, reflecting her interest in interdisciplinary approaches to speech therapy.

Her career took a clinical turn when she worked as a Speech Therapist for the City Hall of Gravatá (2019-2020). Simultaneously, she honed her expertise in hospital-based speech therapy by completing a specialization in Orofacial Motricity with an emphasis on Hospital Speech Therapy and Dysphagia (2019-2021). This specialization enabled her to work closely with patients suffering from swallowing disorders, particularly in hospital settings.

In 2022, Thalita took on a multiprofessional residency in Family Health (RMSF) at UFPE, allowing her to work within an interdisciplinary team to provide holistic patient care. She also engaged in residency training at the Instituto de Medicina Integral Professor Fernando Figueira (IMIP), specializing in physical rehabilitation and hospital speech therapy. However, her medical residency in this area was discontinued in the same year.

In 2023, she expanded her expertise by completing a postgraduate degree in ABA (Applied Behavior Analysis) Intervention for Autism Spectrum Disorder (ASD), emphasizing her commitment to working with neurodivergent populations. She further enriched her knowledge by undertaking a postgraduate specialization in Applied Neuroscience (2024) and Music Therapy (2024), highlighting her interdisciplinary approach to speech therapy.

From 2023 to 2024, Thalita served as a substitute professor in the undergraduate Speech Therapy program at UFPE, where she taught courses in voice, orofacial motricity, dysphagia, language, and educational speech therapy. This role allowed her to share her wealth of clinical experience with future speech therapists, bridging the gap between theory and practice.

Contributions and Research Focus 🔬📖

Thalita’s research contributions are deeply rooted in speech-language pathology, neurological disorders, and rehabilitative interventions. Her Master’s research on Parkinson’s disease focused on how virtual reality and acoustic stimulation could enhance speech therapy outcomes. This innovative approach positioned her at the forefront of using technology-assisted rehabilitation in speech therapy.

She was actively involved in the Pathophysiology of the Stomatognathic System Research Group (2018-2020), where she contributed to studies on orofacial motricity, dysphagia, and related disorders. Her research interests extend to hospital-based speech therapy, multiprofessional health interventions, and neurodevelopmental disorders such as ASD.

Throughout her career, she has contributed to multiple research and extension projects, including educational speech therapy for elementary school students, neonatal hearing screening for high-risk infants, and speech rehabilitation for individuals with Parkinson’s disease. These projects highlight her commitment to improving speech-language interventions across different populations.

Accolades and Recognition 🏆🎖️

Thalita’s academic and professional journey has been marked by a series of achievements and recognitions. Her participation in scientific research, teaching, and clinical practice has earned her prestigious research grants, fellowships, and teaching positions.

She has been recognized for her contributions to interdisciplinary health interventions, particularly in hospital speech therapy and neurodevelopmental rehabilitation. Her role as a mentor and educator at UFPE further underscores her influence in shaping the next generation of speech-language pathologists.

Her leadership in academic leagues, research groups, and community health initiatives has solidified her reputation as a dedicated and influential professional in the field of speech therapy.

Impact and Influence 🌍💡

Thalita’s work has had a profound impact on speech-language therapy, hospital rehabilitation, and community health services. Her research on Parkinson’s disease and acoustic stimulation has contributed valuable insights into alternative therapeutic methods, while her clinical expertise in dysphagia and orofacial motricity has improved patient outcomes in hospital settings.

Her contributions to educational speech therapy have helped shape speech-language interventions for young students, particularly those with speech and language disorders. Her involvement in public health initiatives has played a crucial role in preventing and managing communication disorders at the community level.

Beyond her clinical and research work, Thalita’s role as an educator has been instrumental in inspiring and training new speech therapists. Her dedication to integrating technology, neuroscience, and behavior analysis into speech therapy ensures that her influence extends beyond traditional therapeutic methods.

Legacy and Future Contributions 🚀🔬

Looking ahead, Thalita Victory Silva da Cruz is poised to make even greater contributions to speech-language pathology, rehabilitation sciences, and interdisciplinary healthcare. As a Ph.D. candidate at UFPE, she continues to explore innovative approaches to communication disorders, neurorehabilitation, and hospital-based speech therapy.

Her future research is likely to delve deeper into technological applications in speech therapy, such as virtual reality, AI-driven diagnostics, and acoustic stimulation for neurodegenerative diseases. She is also expected to further expand her work on ASD interventions, educational speech therapy, and hospital-based rehabilitation.

With her strong background in applied neuroscience, behavior analysis, and music therapy, Thalita is uniquely positioned to bridge the gap between traditional speech therapy and modern rehabilitative techniques. Her legacy will be one of innovation, interdisciplinary collaboration, and a deep commitment to improving communication health for diverse populations.

As she continues to educate, research, and advocate, Thalita Victory Silva da Cruz remains a driving force in shaping the future of speech-language pathology, neurological rehabilitation, and public health interventions. 🌟

📝Notable Publications

Acoustic Parameters After Vocal Technique Associated With Virtual Reality With Electromyographic Biofeedback and Rhythmic Auditory Stimulation in Individuals With Parkinson’s Disease

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: Journal of Voice

Year: 2025

 Desempenho do diagrama de desvio fonatório no monitoramento da qualidade vocal pré e pós exercício vocal em indivíduos com Doença de Parkinson

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: CoDAS

Year: 2023

 Performance of the phonatory deviation diagram in monitoring voice quality before and after voice exercise in individuals with Parkinson’s Disease

Author: Thalita Victory Silva da Cruz (and co-authors)

Journal: CoDAS

Year: 2023